Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

181 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Primary intracranial dural B cell small lymphocytic lymphoma.
Giordano A, Perrone T, Guarini A, Ciappetta P, Rubini G, Ricco R, Palma M, Specchia G, Liso V. Giordano A, et al. Among authors: perrone t. Leuk Lymphoma. 2007 Jul;48(7):1437-43. doi: 10.1080/10428190701387021. Leuk Lymphoma. 2007. PMID: 17613779 Review. No abstract available.
Outcome of Very Late Relapse in Patients with Hodgkin's Lymphomas.
Gaudio F, Giordano A, Pavone V, Perrone T, Curci P, Pastore D, Delia M, De' Risi C, Spina A, Liso V, Specchia G. Gaudio F, et al. Among authors: perrone t. Adv Hematol. 2011;2011:707542. doi: 10.1155/2011/707542. Epub 2010 Dec 29. Adv Hematol. 2011. PMID: 21253449 Free PMC article.
Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program.
Ladetto M, Lobetti-Bodoni C, Mantoan B, Ceccarelli M, Boccomini C, Genuardi E, Chiappella A, Baldini L, Rossi G, Pulsoni A, Di Raimondo F, Rigacci L, Pinto A, Galimberti S, Bari A, Rota-Scalabrini D, Ferrari A, Zaja F, Gallamini A, Specchia G, Musto P, Rossi FG, Gamba E, Evangelista A, Vitolo U; Fondazione Italiana Linfomi. Ladetto M, et al. Blood. 2013 Nov 28;122(23):3759-66. doi: 10.1182/blood-2013-06-507319. Epub 2013 Oct 1. Blood. 2013. PMID: 24085766 Free article. Clinical Trial.
Risk of lymphoma subtypes by occupational exposure in Southern Italy.
Ferri GM, Specchia G, Mazza P, Ingravallo G, Intranuovo G, Guastadisegno CM, Congedo ML, Lagioia G, Loparco MC, Giordano A, Perrone T, Gaudio F, Spinosa C, Minoia C, D'Onghia L, Strusi M, Corrado V, Cavone D, Vimercati L, Schiavulli N, Cocco P. Ferri GM, et al. Among authors: perrone t. J Occup Med Toxicol. 2017 Nov 23;12:31. doi: 10.1186/s12995-017-0177-2. eCollection 2017. J Occup Med Toxicol. 2017. PMID: 29201133 Free PMC article.
Brentuximab vedotin as salvage treatment in Hodgkin lymphoma naïve transplant patients or failing ASCT: the real life experience of Rete Ematologica Pugliese (REP).
Pavone V, Mele A, Carlino D, Specchia G, Gaudio F, Perrone T, Mazza P, Palazzo G, Guarini A, Loseto G, Eleonora P, Cascavilla N, Scalzulli P, Melpignano A, Quintana G, Di Renzo N, Tarantini G, Capalbo S. Pavone V, et al. Among authors: perrone t. Ann Hematol. 2018 Oct;97(10):1817-1824. doi: 10.1007/s00277-018-3379-5. Epub 2018 Jul 27. Ann Hematol. 2018. PMID: 30054707
Time to progression of mantle cell lymphoma after high-dose cytarabine-based regimens defines patients risk for death.
Visco C, Tisi MC, Evangelista A, Di Rocco A, Zoellner AK, Zilioli VR, Hohaus S, Sciarra R, Re A, Tecchio C, Chiappella A, Morello L, Gini G, Nassi L, Perrone T, Molinari AL, Fabbri A, Cox MC, Finolezzi E, Ferrero S, Puccini B, Alvarez De Celis I, Arcari A, Marino D, Merli M, Piazza F, Gentile M, Pelosini M, Loseto G, Hermine O, Dreyling M, Ruggeri M, Martelli M, Hoster E, Vitolo U; Fondazione Italiana Linfomi and the Mantle Cell Lymphoma Network. Visco C, et al. Among authors: perrone t. Br J Haematol. 2019 Jun;185(5):940-944. doi: 10.1111/bjh.15643. Epub 2018 Nov 8. Br J Haematol. 2019. PMID: 30407625 Free article. No abstract available.
181 results